TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,053,125 | -34.8% | 37,500 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $3,149,250 | +31.2% | 37,500 | +18.3% | 0.00% | 0.0% |
Q1 2023 | $2,400,641 | +22.7% | 31,700 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,956,524 | +123.1% | 31,700 | +51.0% | 0.00% | – |
Q3 2022 | $877,000 | +32.9% | 21,000 | 0.0% | 0.00% | – |
Q2 2022 | $660,000 | +16.6% | 21,000 | 0.0% | 0.00% | – |
Q1 2022 | $566,000 | +40.8% | 21,000 | 0.0% | 0.00% | – |
Q4 2021 | $402,000 | -47.4% | 21,000 | -9.1% | 0.00% | – |
Q3 2021 | $764,000 | -0.3% | 23,100 | 0.0% | 0.00% | – |
Q2 2021 | $766,000 | -20.0% | 23,100 | 0.0% | 0.00% | – |
Q1 2021 | $958,000 | +95.5% | 23,100 | -6.1% | 0.00% | – |
Q4 2020 | $490,000 | +44.5% | 24,600 | 0.0% | 0.00% | – |
Q3 2020 | $339,000 | -23.1% | 24,600 | 0.0% | 0.00% | – |
Q2 2020 | $441,000 | +94.3% | 24,600 | +30.9% | 0.00% | – |
Q1 2020 | $227,000 | +0.4% | 18,800 | +58.0% | 0.00% | – |
Q4 2019 | $226,000 | -15.0% | 11,900 | +6.2% | 0.00% | – |
Q3 2019 | $266,000 | – | 11,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KPCB XIII Associates, LLC | 923,221 | $30,632,000 | 5.64% |
Sandhill Capital Partners LLC | 1,429,432 | $47,429,000 | 3.70% |
Bullseye Asset Management LLC | 117,471 | $3,898,000 | 1.31% |
Taylor Wealth Management Partners | 72,685 | $2,412,000 | 0.85% |
Signature Wealth Management Partners, LLC | 14,000 | $465,000 | 0.42% |
EMERALD MUTUAL FUND ADVISERS TRUST | 369,259 | $12,252,000 | 0.40% |
Triumph Capital Management | 20,051 | $622,000 | 0.36% |
EMERALD ADVISERS, LLC | 300,464 | $9,969,000 | 0.36% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,347 | $2,533,000 | 0.30% |
Bellevue Group AG | 729,989 | $24,221,000 | 0.24% |